Sees FY25 revenue $2.8B-$2.9B, consensus $2.85B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Is GMED a Buy, Before Earnings?
- Globus Medical price target lowered to $90 from $97 at Canaccord
- Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns
- Optimistic Outlook on Globus Medical: Strategic Changes and Positive Q2 Performance Drive Buy Rating
- Globus Medical price target lowered to $88 from $90 at Jefferies